These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12148265)

  • 41. Methicillin-resistant staphylococci as an epidemiological indication for gentamicin therapy.
    Ericson C; Larsson S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973; ():Suppl 241:65-8. PubMed ID: 4521609
    [No Abstract]   [Full Text] [Related]  

  • 42. Ophthalmia neonatorum: what kind of prophylaxis?
    Zuppa AA; D'Andrea V; Catenazzi P; Scorrano A; Romagnoli C
    J Matern Fetal Neonatal Med; 2011 Jun; 24(6):769-73. PubMed ID: 21534852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel].
    Staemmler HG; Rodeck H; Linzenmeier G
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1714-6. PubMed ID: 5668265
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic contact dermatitis due to fusidic acid.
    De Castro Martinez FJ; Ruiz FJ; Tornero P; De Barrio M; Prieto A
    Contact Dermatitis; 2006 Mar; 54(3):169. PubMed ID: 16524442
    [No Abstract]   [Full Text] [Related]  

  • 45. Sodium fusidate in steroid resistant relapses of multiple sclerosis.
    Nicoletti F; Patti F; Nicoletti A; L'Espiscopo MR; DiMarco R; Bendtzen K; Reggio A
    Mult Scler; 1999 Dec; 5(6):377. PubMed ID: 10644161
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
    Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rhabdomyolysis with atorvastatin and fusidic acid.
    O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
    Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro antimicrobial findings for fusidic acid tested against contemporary (2008-2009) gram-positive organisms collected in the United States.
    Jones RN; Mendes RE; Sader HS; Castanheira M
    Clin Infect Dis; 2011 Jun; 52 Suppl 7():S477-86. PubMed ID: 21546624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe?
    Hon KL; Wang SS; Lee KK; Lee VW; Leung TF; Ip M
    J Drugs Dermatol; 2012 Jul; 11(7):861-4. PubMed ID: 22777230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fusidic acid and heparin lock solution for the prevention of catheter-related bloodstream infections in critically ill neonates: a retrospective study and a prospective, randomized trial.
    Filippi L; Pezzati M; Di Amario S; Poggi C; Pecile P
    Pediatr Crit Care Med; 2007 Nov; 8(6):556-62. PubMed ID: 17914310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fusidic acid plus betamethasone in infected or potentially infected eczema.
    Hjorth N; Schmidt H; Thomsen K
    Pharmatherapeutica; 1985; 4(2):126-31. PubMed ID: 3903779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prolonged use of intravenous fusidic acid in severe staphylococcal infection.
    Copperman IJ
    Br J Clin Pract; 1972 Feb; 26(2):83-4. PubMed ID: 5016911
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental purulent meningitis and its treatment with antibiotics].
    Petrova MA; Koroleva VG; Berezina EK
    Antibiotiki; 1974 May; 19(5):422-7. PubMed ID: 4219126
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
    Levine C; Trivedi A; Thung SN; Perumalswami PV
    Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
    Macotela-Ruiz E; Durán Bermúdez H; Kuri Con FJ; Arevalo López A; Villalobos Ibarra JL
    Med Cutan Ibero Lat Am; 1988; 16(2):171-3. PubMed ID: 3050336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fusidic acid adverse drug reactions.
    Christiansen K
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S3-9. PubMed ID: 10528781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.
    Peter JD; Jehl F; Pottecher T; Dupeyron JP; Monteil H
    Antimicrob Agents Chemother; 1993 Mar; 37(3):501-6. PubMed ID: 8460918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatotoxicity and hematologic complications induced by fusidic acid in a patient with hepatitis B cirrhosis: A case report.
    He ZF; Chen L; Zhang JP; Wang QQ
    Medicine (Baltimore); 2019 Nov; 98(45):e17852. PubMed ID: 31702645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancytopenia in a patient treated with fusidic acid and niraparib: a case report.
    Damerval M; Bazan F; Omrani S; Hugues M; Roux MF; Mayer J
    Eur J Hosp Pharm; 2023 Sep; 30(5):e24. PubMed ID: 35232830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.